Home » Topics » BioWorld

BioWorld
RSS

BIG NAMES BOLSTER ICOS OFFERING

April 9, 1992

GENZYME, XENOVA TO COLLABORATE

April 9, 1992

DEAL TO DELAY UBS STOCK DISTRIBUTION

April 8, 1992

MARKET UNDERTOW GRABS BIOTECH STOCKS

April 8, 1992

OPTIMISM ON CENTOXIN ISN'T UNANIMOUS

April 8, 1992

PATENT ON POSITIVE IMAGING TECHNIQUE

April 8, 1992

CEPHALON LAUNCHES ALS TRIALS

April 8, 1992

STEM CELL ISOLATION TECHNIQUE

April 8, 1992

U.K. COMPANY ENTERS U.S. IPO MARKET

April 8, 1992

PATCH DEVELOPER RAISES $17.5 MILLION

April 8, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.